Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:50 UTC |
---|
Update Date | 2022-03-07 02:51:45 UTC |
---|
HMDB ID | HMDB0014826 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Mycophenolate mofetil |
---|
Description | Mycophenolate mofetil is only found in individuals that have used or taken this drug. It is the 2-morpholinoethyl ester of mycophenolic acid (MPA), an immunosuppressive agent, inosine monophosphate dehydrogenase (IMPDH) inhibitor.Mycophenolate mofetil is hydrolyzed to form mycophenolic acid (MPA), which is the active metabolite. MPA is a potent, selective, uncompetitive, and reversible inhibitor of inosine monophosphate dehydrogenase (IMPDH), and therefore inhibits the de novo pathway of guanosine nucleotide synthesis without incorporation into DNA. Because T- and B-lymphocytes are critically dependent for their proliferation on de novo synthesis of purines, whereas other cell types can utilize salvage pathways, MPA has potent cytostatic effects on lymphocytes. MPA inhibits proliferative responses of T- and B-lymphocytes to both mitogenic and allospecific stimulation. Addition of guanosine or deoxyguanosine reverses the cytostatic effects of MPA on lymphocytes. MPA also suppresses antibody formation by B-lymphocytes. MPA prevents the glycosylation of lymphocyte and monocyte glycoproteins that are involved in intercellular adhesion to endothelial cells and may inhibit recruitment of leukocytes into sites of inflammation and graft rejection. Mycophenolate mofetil did not inhibit early events in the activation of human peripheral blood mononuclear cells, such as the production of interleukin-1 (IL-1) and interleukin-2 (IL-2), but did block the coupling of these events to DNA synthesis and proliferation. |
---|
Structure | COC1=C(C\C=C(/C)CCC(=O)OCCN2CCOCC2)C(O)=C2C(=O)OCC2=C1C InChI=1S/C23H31NO7/c1-15(5-7-19(25)30-13-10-24-8-11-29-12-9-24)4-6-17-21(26)20-18(14-31-23(20)27)16(2)22(17)28-3/h4,26H,5-14H2,1-3H3/b15-4+ |
---|
Synonyms | Value | Source |
---|
2-Morpholinoethyl (e)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate | ChEBI | Cellcept | ChEBI | MMF | ChEBI | Mycophenolic acid morpholinoethyl ester | ChEBI | RS 61443 | ChEBI | 2-Morpholinoethyl (e)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoic acid | Generator | Mycophenolate morpholinoethyl ester | Generator | Mycophenolic acid mofetil | Generator | Mycophenylate mofetil | HMDB | Mycophenolate sodium | HMDB | Myfortic | HMDB | Sodium mycophenolate | HMDB | Mycophenolate mofetil hydrochloride | HMDB | Mofetil hydrochloride, mycophenolate | HMDB | Mofetil, mycophenolate | HMDB | Mycophenolate, sodium | HMDB | Mycophenolic acid | HMDB |
|
---|
Chemical Formula | C23H31NO7 |
---|
Average Molecular Weight | 433.4947 |
---|
Monoisotopic Molecular Weight | 433.210052351 |
---|
IUPAC Name | 2-(morpholin-4-yl)ethyl (4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydro-2-benzofuran-5-yl)-4-methylhex-4-enoate |
---|
Traditional Name | mycophenolate mofetil |
---|
CAS Registry Number | 128794-94-5 |
---|
SMILES | COC1=C(C\C=C(/C)CCC(=O)OCCN2CCOCC2)C(O)=C2C(=O)OCC2=C1C |
---|
InChI Identifier | InChI=1S/C23H31NO7/c1-15(5-7-19(25)30-13-10-24-8-11-29-12-9-24)4-6-17-21(26)20-18(14-31-23(20)27)16(2)22(17)28-3/h4,26H,5-14H2,1-3H3/b15-4+ |
---|
InChI Key | RTGDFNSFWBGLEC-SYZQJQIISA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as phthalides. Phthalides are compounds containing a 3-hydrocarbylidene-2-benzofuran-1(3H)-one moiety,. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Isocoumarans |
---|
Sub Class | Isobenzofuranones |
---|
Direct Parent | Phthalides |
---|
Alternative Parents | |
---|
Substituents | - Phthalide
- Anisole
- Alkyl aryl ether
- Fatty acid ester
- Dicarboxylic acid or derivatives
- Morpholine
- Oxazinane
- Fatty acyl
- Benzenoid
- Vinylogous acid
- Amino acid or derivatives
- Carboxylic acid ester
- Lactone
- Tertiary amine
- Tertiary aliphatic amine
- Ether
- Dialkyl ether
- Carboxylic acid derivative
- Oxacycle
- Azacycle
- Organonitrogen compound
- Hydrocarbon derivative
- Organic nitrogen compound
- Organic oxide
- Organopnictogen compound
- Amine
- Carbonyl group
- Organooxygen compound
- Organic oxygen compound
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 0.095 g/L | Not Available | LogP | 2.5 | Not Available |
|
---|
Experimental Chromatographic Properties | Experimental Collision Cross Sections |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatized |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Mycophenolate mofetil GC-MS (Non-derivatized) - 70eV, Positive | splash10-0w4i-2393200000-d549469b4d276b82f0a4 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Mycophenolate mofetil GC-MS (1 TMS) - 70eV, Positive | splash10-0itd-4629600000-670072fd9bb0a49d7de1 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Mycophenolate mofetil GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Mycophenolate mofetil , positive-QTOF | splash10-0019-1741900000-022d7009668cda105e50 | 2017-09-14 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mycophenolate mofetil 10V, Positive-QTOF | splash10-01q9-0743900000-133a311844263f919bdd | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mycophenolate mofetil 20V, Positive-QTOF | splash10-03di-1961100000-5da439d2a9f8cae8f445 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mycophenolate mofetil 40V, Positive-QTOF | splash10-03xr-9740100000-6af6a8b42b2977762a4c | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mycophenolate mofetil 10V, Negative-QTOF | splash10-0f89-0419700000-cbea334d70b0f1f93d90 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mycophenolate mofetil 20V, Negative-QTOF | splash10-0ue9-2859500000-742b323b12fbfbe7a502 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mycophenolate mofetil 40V, Negative-QTOF | splash10-0fe3-9564000000-dd2d4e0510f30a121c4e | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mycophenolate mofetil 10V, Positive-QTOF | splash10-001i-0020900000-038b179f46cd4955dd10 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mycophenolate mofetil 20V, Positive-QTOF | splash10-0a4i-0291200000-8369d80f2ca22af88fba | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mycophenolate mofetil 40V, Positive-QTOF | splash10-03di-0960100000-828ad4ec3f0767246892 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mycophenolate mofetil 10V, Negative-QTOF | splash10-001i-0501900000-6ec023ec52bc4a8e5ea1 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mycophenolate mofetil 20V, Negative-QTOF | splash10-004l-2921100000-7173e63d30a5885f9a87 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mycophenolate mofetil 40V, Negative-QTOF | splash10-00or-1590000000-77b54540de37ccf344ec | 2021-10-11 | Wishart Lab | View Spectrum |
|
---|
General References | - Picard N, Cresteil T, Premaud A, Marquet P: Characterization of a phase 1 metabolite of mycophenolic acid produced by CYP3A4/5. Ther Drug Monit. 2004 Dec;26(6):600-8. [PubMed:15570183 ]
- Woodroffe R, Yao GL, Meads C, Bayliss S, Ready A, Raftery J, Taylor RS: Clinical and cost-effectiveness of newer immunosuppressive regimens in renal transplantation: a systematic review and modelling study. Health Technol Assess. 2005 May;9(21):1-179, iii-iv. [PubMed:15899149 ]
- (). FDA label . .
|
---|